ACH|Accendra Health Ord Shs|Price:2.390|Chg%:0.18

More Details of Company

Accendra Health Ord Shs Info



Ticker Symbol- -

Company name- -

IPO date- -

CEO- -

Number of employees- -

Security type- -

Fiscal year-end- -

Address- -

City- -

Stock exchange- -

Country- -

Postal code- -

Phone- -

Website- -

Ticker Symbol- -

IPO date- -

CEO- -

Company Executives of Accendra Health Ord Shs



Name

Name/Position

Position

Shareholding

Change

Mr. Edward A. Pesicka

President, Chief Executive Officer, Director

1.15M

-35208.00%

Mr. Perry A. Bernocchi

Chief Operating Officer, Executive Vice President

233.97K

-13394.00%

Mr. Jonathan A. Leon

Chief Financial Officer, Executive Vice President, Principal Accounting Officer

218.52K

-4265.00%

Mr. Robert J. (Bob) Henkel

Independent Director

66.26K

+28914.00%

Mr. Kenneth (Kenny) Gardner-Smith

Independent Director

54.92K

+28914.00%

Lt. Gen. Gwendolyn M. Bingham

Independent Director

22.18K

--

Mr. Mark A. Beck

Independent Chairman of the Board

--

Mr. Stephen W. (Steve) Klemash

Independent Director

--

Ms. Rita F. Johnson-Mills

Independent Director

--

Ms. Teresa L. Kline

Independent Director

--

Name

Name/Position

Position

Shareholding

Change

Mr. Edward A. Pesicka

President, Chief Executive Officer, Director

1.15M

-35208.00%

Mr. Perry A. Bernocchi

Chief Operating Officer, Executive Vice President

233.97K

-13394.00%

Mr. Jonathan A. Leon

Chief Financial Officer, Executive Vice President, Principal Accounting Officer

218.52K

-4265.00%

Mr. Robert J. (Bob) Henkel

Independent Director

66.26K

+28914.00%

Mr. Kenneth (Kenny) Gardner-Smith

Independent Director

54.92K

+28914.00%

Lt. Gen. Gwendolyn M. Bingham

Independent Director

22.18K

--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2021

FY2020

FY2019

By BusinessUSD

Name

Revenue

Proportion

Diabetes

201.37M

28.88%

Sleep therapy

185.80M

26.65%

Home respiratory therapy

107.26M

15.38%

Other

72.59M

10.41%

Ostomy

53.27M

7.64%

Other

76.98M

11.04%

Relevant data have not been disclosed by the company yet.

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Diabetes

201.37M

28.88%

Sleep therapy

185.80M

26.65%

Home respiratory therapy

107.26M

15.38%

Other

72.59M

10.41%

Ostomy

53.27M

7.64%

Other

76.98M

11.04%

Shareholding Stats

Updated: 8 hours ago

Shareholders

Shareholder Types

Shareholders

Proportion

Coliseum Capital Management, L.L.C.

16.94%

The Vanguard Group, Inc.

7.80%

BlackRock Institutional Trust Company, N.A.

6.32%

Dimensional Fund Advisors, L.P.

4.53%

Millennium Management LLC

4.22%

Other

60.20%

Shareholders

Proportion

Coliseum Capital Management, L.L.C.

16.94%

The Vanguard Group, Inc.

7.80%

BlackRock Institutional Trust Company, N.A.

6.32%

Dimensional Fund Advisors, L.P.

4.53%

Millennium Management LLC

4.22%

Other

60.20%

Shareholder Types

Shareholders

Proportion

Hedge Fund

37.60%

Investment Advisor

32.82%

Investment Advisor/Hedge Fund

21.10%

Research Firm

5.16%

Individual Investor

3.66%

Pension Fund

0.48%

Bank and Trust

0.44%

Venture Capital

0.23%

Sovereign Wealth Fund

0.06%

Institutional Shareholding



Updated: Sat, Jan 3

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2026Q1

506

75.40M

97.49%

-21.05M

2025Q4

534

75.70M

97.87%

-18.86M

2025Q3

546

76.01M

98.30%

-20.79M

2025Q2

540

78.13M

101.97%

-17.96M

2025Q1

543

77.64M

100.50%

-19.65M

2024Q4

538

79.04M

102.40%

-14.25M

2024Q3

552

79.41M

103.01%

-12.06M

2023Q4

582

79.41M

103.81%

-13.04M

2023Q2

583

76.62M

100.55%

-10.57M

2023Q1

597

75.96M

99.69%

-10.66M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

Coliseum Capital Management, L.L.C.

13.10M

16.96%

+1.54M

+13.30%

Sep 30, 2025

The Vanguard Group, Inc.

5.75M

7.43%

-2.15M

-27.27%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

4.88M

6.32%

-5.09M

-51.04%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

3.51M

4.53%

-750.61K

-17.63%

Sep 30, 2025

Millennium Management LLC

3.26M

4.22%

+2.14M

+191.71%

Sep 30, 2025

Charles Schwab Investment Management, Inc.

3.21M

4.15%

+133.51K

+4.34%

Sep 30, 2025

Invenomic Capital Management LP

2.75M

3.55%

+2.75M

--

Sep 30, 2025

Paradigm Capital Management, Inc.

2.61M

3.38%

+632.90K

+31.99%

Sep 30, 2025

D. E. Shaw & Co., L.P.

2.32M

3%

+890.92K

+62.34%

Sep 30, 2025

State Street Investment Management (US)

1.96M

2.54%

-1.13M

-36.45%

Sep 30, 2025

Related ETFs



Updated: Sat, Jan 3

Name

Proportion

State Street SPDR S&P Health Care Services ETF

0.36%

Royce Quant Small-Cap Quality Value ETF

0.27%

DoubleLine Fortune 500 Equal Weight ETF

0.22%

Vanguard US Value Factor ETF

0.12%

Indexperts Quality Earnings Focused ETF

0.11%

Schwab Fundamental U.S. Small Company ETF

0.07%

First Trust Active Factor Small Cap ETF

0.04%

WisdomTree US SmallCap Fund

0.03%

Invesco Russell 2000 Dynamic Multifactor ETF

0.03%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.02%

State Street SPDR S&P Health Care Services ETF

Proportion0.36%

Royce Quant Small-Cap Quality Value ETF

Proportion0.27%

DoubleLine Fortune 500 Equal Weight ETF

Proportion0.22%

Vanguard US Value Factor ETF

Proportion0.12%

Indexperts Quality Earnings Focused ETF

Proportion0.11%

Schwab Fundamental U.S. Small Company ETF

Proportion0.07%

First Trust Active Factor Small Cap ETF

Proportion0.04%

WisdomTree US SmallCap Fund

Proportion0.03%

Invesco Russell 2000 Dynamic Multifactor ETF

Proportion0.03%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

Proportion0.02%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Splits



Date

Ex-dividend Date

Type

Ratio

No Data

Date

Ex-dividend Date

Type

Ratio

No Data